Growth Metrics

UNITED THERAPEUTICS (UTHR) Accumulated Depreciation & Amortization: 2009-2025

Historic Accumulated Depreciation & Amortization for UNITED THERAPEUTICS (UTHR) over the last 6 years, with Sep 2025 value amounting to $21.9 million.

  • UNITED THERAPEUTICS's Accumulated Depreciation & Amortization rose 14.66% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.5 million, marking a year-over-year increase of 24.06%. This contributed to the annual value of $72.5 million for FY2024, which is 36.28% up from last year.
  • As of Q3 2025, UNITED THERAPEUTICS's Accumulated Depreciation & Amortization stood at $21.9 million, which was up 3.79% from $21.1 million recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Accumulated Depreciation & Amortization registered a high of $21.9 million during Q3 2025, and its lowest value of $12.4 million during Q2 2021.
  • For the 3-year period, UNITED THERAPEUTICS's Accumulated Depreciation & Amortization averaged around $17.1 million, with its median value being $18.7 million (2024).
  • Per our database at Business Quant, UNITED THERAPEUTICS's Accumulated Depreciation & Amortization fell by 3.82% in 2021 and then surged by 44.96% in 2024.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Accumulated Depreciation & Amortization stood at $12.6 million in 2021, then increased by 4.76% to $13.2 million in 2022, then climbed by 3.79% to $13.7 million in 2023, then spiked by 43.80% to $19.7 million in 2024, then increased by 14.66% to $21.9 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $21.9 million for Q3 2025, versus $21.1 million for Q2 2025 and $19.8 million for Q1 2025.